www.thepcrj.org doi:10.3132/pcrj.2008.00043 Pharmacological profile, efficacy and safety of rupatadine in allergic rhiniti
Background: Allergic rhinitis (AR) is one of the most prevalent atopic disorders that affect product...
FUTURA STUDY-Evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent...
Eva Santamaría,1,2 Iñaki Izquierdo,2 Marta Valle,1,3 Jan Vermeulen,4 Paul Potter5 1Dep...
Introduction: Rupatadine is a second-generation H-1-antihistamine with dual affinity for histamine H...
BACKGROUND: Allergic rhinitis has reached epidemic levels for years in Belgium and substantially imp...
The second-generation antihistamine rupatadine is a new long-acting and non-sedating drug that exert...
Objective: Long-term safety and efficacy of 10- and 20-mg rupatadine in Japanese patients with peren...
Abstract: Allergic rhinitis is a common condition that affects 10%–20 % of general population. Seaso...
SummaryAllergic rhinitis affects 10-30% of the population, negatively impacting one's quality of lif...
In a review of rupatadine published in 2008, the primary focus was on its role as an antihistamine, ...
Univ Sao Paulo, Dept Otolaryngol, Sao Paulo, BrazilUniv Sao Paulo, Dept Allergy & Immunol, Sao Paulo...
Abstract Background Different clinical trials showed the superior efficacy of rupatadine compared to...
International audienceBackground The clinical efficacy of rupatadine in terms of responders has not ...
Background: Rupatadine is a novel non-sedating second-generation H1-antihistamine with antiplatelet-...
Histamine is the primary mediator involved the pathophysiology of allergic rhinitis and chronic urti...
Background: Allergic rhinitis (AR) is one of the most prevalent atopic disorders that affect product...
FUTURA STUDY-Evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent...
Eva Santamaría,1,2 Iñaki Izquierdo,2 Marta Valle,1,3 Jan Vermeulen,4 Paul Potter5 1Dep...
Introduction: Rupatadine is a second-generation H-1-antihistamine with dual affinity for histamine H...
BACKGROUND: Allergic rhinitis has reached epidemic levels for years in Belgium and substantially imp...
The second-generation antihistamine rupatadine is a new long-acting and non-sedating drug that exert...
Objective: Long-term safety and efficacy of 10- and 20-mg rupatadine in Japanese patients with peren...
Abstract: Allergic rhinitis is a common condition that affects 10%–20 % of general population. Seaso...
SummaryAllergic rhinitis affects 10-30% of the population, negatively impacting one's quality of lif...
In a review of rupatadine published in 2008, the primary focus was on its role as an antihistamine, ...
Univ Sao Paulo, Dept Otolaryngol, Sao Paulo, BrazilUniv Sao Paulo, Dept Allergy & Immunol, Sao Paulo...
Abstract Background Different clinical trials showed the superior efficacy of rupatadine compared to...
International audienceBackground The clinical efficacy of rupatadine in terms of responders has not ...
Background: Rupatadine is a novel non-sedating second-generation H1-antihistamine with antiplatelet-...
Histamine is the primary mediator involved the pathophysiology of allergic rhinitis and chronic urti...
Background: Allergic rhinitis (AR) is one of the most prevalent atopic disorders that affect product...
FUTURA STUDY-Evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent...
Eva Santamaría,1,2 Iñaki Izquierdo,2 Marta Valle,1,3 Jan Vermeulen,4 Paul Potter5 1Dep...
DOI
Add to ORKG